175 related articles for article (PubMed ID: 32394495)
1. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented.
Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495
[TBL] [Abstract][Full Text] [Related]
2. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
Yebyo HG; Zappacosta S; Aschmann HE; Haile SR; Puhan MA
BMC Cardiovasc Disord; 2020 Sep; 20(1):418. PubMed ID: 32942999
[TBL] [Abstract][Full Text] [Related]
3. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
Zhao B; He X; Wu J; Yan S
BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
[TBL] [Abstract][Full Text] [Related]
4. Inception and deprescribing of statins in people aged over 80 years: cohort study.
Gulliford M; Ravindrarajah R; Hamada S; Jackson S; Charlton J
Age Ageing; 2017 Nov; 46(6):1001-1005. PubMed ID: 29088364
[TBL] [Abstract][Full Text] [Related]
5. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012-2018).
Liu Y; Lv X; Xie N; Fang Z; Ren W; Gong Y; Jin Y; Zhang J
BMC Cardiovasc Disord; 2020 Apr; 20(1):201. PubMed ID: 32334525
[TBL] [Abstract][Full Text] [Related]
6. Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction.
Booth JN; Colantonio LD; Rosenson RS; Safford MM; Chen L; Kilgore ML; Brown TM; Taylor B; Dent R; Monda KL; Muntner P; Levitan EB
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739799
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in the Use of Statins in Community Practice.
Nanna MG; Wang TY; Xiang Q; Goldberg AC; Robinson JG; Roger VL; Virani SS; Wilson PWF; Louie MJ; Koren A; Li Z; Peterson ED; Navar AM
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005562. PubMed ID: 31416347
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
[TBL] [Abstract][Full Text] [Related]
9. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.
Booth JN; Colantonio LD; Chen L; Rosenson RS; Monda KL; Safford MM; Kilgore ML; Brown TM; Taylor B; Dent R; Muntner P; Levitan EB
Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29021332
[TBL] [Abstract][Full Text] [Related]
10. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database.
Vinogradova Y; Coupland C; Brindle P; Hippisley-Cox J
BMJ; 2016 Jun; 353():i3305. PubMed ID: 27353261
[TBL] [Abstract][Full Text] [Related]
12. Statin adherence and risk of acute cardiovascular events among women: a cohort study accounting for time-dependent confounding affected by previous adherence.
Lavikainen P; Helin-Salmivaara A; Eerola M; Fang G; Hartikainen J; Huupponen R; Korhonen MJ
BMJ Open; 2016 Jun; 6(6):e011306. PubMed ID: 27259530
[TBL] [Abstract][Full Text] [Related]
13. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
Sofat S; Chen X; Chowdhury MM; Coughlin PA
Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
[TBL] [Abstract][Full Text] [Related]
14. Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study.
Laleman N; Henrard S; van den Akker M; Goderis G; Buntinx F; Van Pottelbergh G; Vaes B
BMC Cardiovasc Disord; 2018 Nov; 18(1):209. PubMed ID: 30400778
[TBL] [Abstract][Full Text] [Related]
15. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Danninger K; Hoppe UC; Pieringer H
Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
[TBL] [Abstract][Full Text] [Related]
16. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of statin therapy.
Adhyaru BB; Jacobson TA
Nat Rev Cardiol; 2018 Dec; 15(12):757-769. PubMed ID: 30375494
[TBL] [Abstract][Full Text] [Related]
18. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
19. Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review.
Vonbank A; Drexel H; Agewall S; Lewis BS; Dopheide JF; Kjeldsen K; Ceconi C; Savarese G; Rosano G; Wassmann S; Niessner A; Schmidt TA; Saely CH; Baumgartner I; Tamargo J
Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):230-236. PubMed ID: 30099530
[TBL] [Abstract][Full Text] [Related]
20. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
